Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)
25.83
-0.51 (-1.94%)
Oct 14, 2026, 11:29 AM CST
SHA:688399 Market Cap
SHA:688399 has a market cap or net worth of 3.21 billion as of October 13, 2026. It is the 15,101st most valuable company in the world and the 4,121st biggest in China. Its market cap has decreased by 43.88% in one year.
Market Cap
3.21B
Enterprise Value
2.05B
Revenue
310.89M
Global Rank
Country Rank
#4,121 China
PE Ratio
n/a
ChartMarket Cap Chart
Since December 5, 2019, SHA:688399's market cap has decreased from 3.22B to 3.21B, a decrease of -0.34%. That is a compound annual growth rate of -0.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 3.21B | -44.19% |
| Dec 31, 2025 | 5.75B | 54.17% |
| Dec 31, 2024 | 3.73B | 16.52% |
| Dec 29, 2023 | 3.20B | -37.80% |
| Dec 30, 2022 | 5.14B | -36.21% |
| Dec 31, 2021 | 8.06B | -28.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pulike Biological Engineering | 3.50B |
| Jiangsu Sihuan Bioengineering | 3.50B |
| Shanghai Shen Lian Biomedical | 3.37B |
| Qingdao Vland Biotech INC. | 3.37B |
| Lifecome Biochemistry | 3.31B |
| Baolingbao Biology | 3.20B |
| Hinova Pharmaceuticals | 3.18B |
| Guanhao Biotech | 3.15B |